Protein (4)Cell (1)
En ligne (5)
Human (5)
- (2)His Tag & Avi Tag & Flag Tag (1)His Tag & Flag Tag (1)His Tag (1)
Unconjugated (3)- (1)Biotin-labeled (1)
| Numéro de produit | Espèces | Système d'expression | Description du produit | Structure protéique | Pureté | Caractéristiques | Pré-commande/Commande |
|---|---|---|---|---|---|---|---|
CHEK-ATP124 | HEK293 | HEK293/Human Claudin-1 Stable Cell Line | |||||
CL1-H52D3 | HEK293 | Human Claudin-1 Full Length Protein, Flag,His Tag (Detergent) | ![]() | ||||
CL1-H52P6 | HEK293 | Human Claudin-1 Full Length Protein (VLP) | |||||
CL1-H55H3 | InsectCells | Human Claudin-1 Full Length Protein, His Tag (Nanodisc-pro) | |||||
CL1-H82D3 | HEK293 | Biotinylated Human Claudin-1 Protein, Flag Tag&His,Avitag™ (Detergent) | ![]() |
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Monalizumab | NN-8765; IPH-2201; NNC-0141-0000-0100 | Phase 3 Clinical | Innate Pharma, Novo Nordisk A/S | Breast Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Esophageal Squamous Cell Carcinoma; Mouth Neoplasms; Carcinoma, Squamous Cell; Esophageal adenocarcinoma; Inflammation; Genital Neoplasms, Female; Colorectal Neoplasms; Head and Neck Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Arthritis, Rheumatoid; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Hematologic Neoplasms; Solid tumours | Details |
| BMS-986315 | BMS-986315 | Phase 2 Clinical | Bristol-Myers Squibb Company | Solid tumours; Carcinoma, Non-Small-Cell Lung | Details |
| S-095029 | S-095029 | Phase 2 Clinical | Institut De Recherches Internationales Servier | Solid tumours; Esophageal Neoplasms; Mismatch Repair Deficient Cancer; Stomach Neoplasms; Microsatellite instability-high cancer; Carcinoma, Non-Small-Cell Lung | Details |
| BRY-805 | BRY805; BRY-805 | Phase 1 Clinical | BioRay Pharmaceutical Co Ltd | Solid tumours | Details |
| HY000102 | HY-0102; HY-000102 | Phase 1 Clinical | Shanghai HyaMab Biotech Co Ltd | Solid tumours; Pancreatic Neoplasms | Details |






